Doggy diarrhea biotech tries IPO attempt #2: Jaguar Animal Health set for $22 … – Nasdaq

Doggy diarrhea biotech tries IPO attempt #2: Jaguar Animal Health set for $ 22
Nasdaq
Jaguar Animal Health, which is developing an animal formulation of its parent's approved diarrhea treatment, announced terms for its IPO on Friday. The San Francisco, CA-based company plans to raise $ 22 million by offering 3.2 million shares at a price

diarrhea – Google News